Variation of PPARG Expression in Chemotherapy-Sensitive Patients of Hypopharyngeal Squamous Cell Carcinoma

Variation of PPARG Expression in Chemotherapy-Sensitive Patients of Hypopharyngeal Squamous Cell Carcinoma

Our previous study showed that the upregulation of peroxisome proliferator-activated receptor gamma (PPARG) could promote chemosensitivity of hypopharyngeal squamous cell carcinoma (HSCC) in chemotherapeutic treatments. Here, we acquired two more independent expression data of PPARG to validate the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Meng Lian, Yong Tao, Jiaming Chen, Xixi Shen, Lizhen Hou, Shaolong Cao, Jugao Fang
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2021/5525091
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PPARG and the PTEN-PI3K/AKT Signaling Axis May Cofunction in Promoting Chemosensitivity in Hypopharyngeal Squamous Cell Carcinoma
by: Boxuan Han, et al.
Published: (2024-01-01)

The association between diabetes and head and neck squamous cell carcinoma: evidence from clinical cohort and bioinformatics analyses
by: Yurong He, et al.
Published: (2025-08-01)

The clinical outcomes of induction chemotherapy followed by radiotherapy vs. chemoradiotherapy in locally advanced hypopharyngeal squamous cell carcinoma: A retrospective study
by: Ke Jiang, et al.
Published: (2024-10-01)

Inflammation as a mediator between neck adipose tissue and tumor aggressiveness in hypopharyngeal and laryngeal squamous cell carcinoma
by: Yu Jiang, et al.
Published: (2025-07-01)

CeRNA network reveals potential diagnostic biomarkers or immunotherapy targets for Hypopharyngeal squamous cell carcinoma
by: Xi Yang, et al.
Published: (2025-09-01)

Explore the possible influence of Sjogren's syndrome on thyroid cancer: A literature data mining and meta-analysis.
by: Fanyong Kong, et al.
Published: (2025-01-01)

The association between level IV/V metastasis and the recurrence, distant metastasis, and survival outcomes in hypopharyngeal squamous cell carcinoma
by: Ruichen Li, et al.
Published: (2025-01-01)

Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis
by: Arikin Abdeyrim, et al.
Published: (2020-05-01)

The Genetics of PPARG and the Skeleton
by: Cheryl Ackert-Bicknell, et al.
Published: (2006-01-01)

Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report
by: Guoning Yu, et al.
Published: (2025-06-01)

Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer
by: Gaofei Yin, et al.
Published: (2025-02-01)

A Novel Survival Prediction Nomogram Based on the Naples Prognostic Score and Clinicopathological Factors for Postoperative Hypopharyngeal Squamous Cell Carcinoma Patients
by: Xu XL, et al.
Published: (2025-06-01)

Hypopharyngeal Squamous Cell Carcinoma in Elderly Patients Aged &ge;70 Years: Surgery and Postoperative Radiotherapy Improves Outcomes in Selected Patients
by: Wang R, et al.
Published: (2025-07-01)

Boerhaave syndrome due to hypopharyngeal stenosis associated with chemoradiotherapy for hypopharyngeal cancer: a case report
by: Hideharu Tanaka, et al.
Published: (2018-06-01)

Endoscopic submucosal dissection for hypopharyngeal cancer simultaneous with immunotherapy for renal cell carcinoma
by: Tatsuro Hirao, et al.
Published: (2025-04-01)

Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma
by: Dietz, Andreas, et al.
Published: (2025-06-01)

Craniocaudal spread patterns of retropharyngeal lymph node metastasis in patients with hypopharyngeal carcinoma
by: Satomi Yoshimi, et al.
Published: (2025-05-01)

Excellent response of cetuximab plus chemotherapy after pembrolizumab monotherapy in metastatic hypopharyngeal cancer: A case report
by: Anh Tuan Pham, et al.
Published: (2025-03-01)

The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series
by: Pichit Sittitrai, et al.
Published: (2018-10-01)

Gene mutations and differentiation in laryngeal and pharyngeal squamous cell carcinoma
by: Gaofei Yin, et al.
Published: (2025-04-01)

Imaging-based evaluation of cervical muscle mass and 6-month survival in males with hypopharyngeal carcinoma
by: Jouni Laurén, et al.
Published: (2024-12-01)

Genetic Variability of RXRB, PPARA, and PPARG in Wegener's Granulomatosis
by: Stefan Wieczorek, et al.
Published: (2009-01-01)

Surgical management of hypopharyngeal cancer (narrative review)
by: N. N. Radzhabova, et al.
Published: (2019-07-01)

Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report
by: Ying Sun, et al.
Published: (2024-12-01)

Utility of ultrasound examination in the diagnosis of laryngeal and hypopharyngeal cancers
by: G. F. Allakhverdieva, et al.
Published: (2019-07-01)

Oyster Mushroom (Pleurotus ostreatus) Ethanolic Extract Inhibits Pparg Expression While Maintaining the Methylation of the Pparg Promoter During 3T3-L1 Adipocyte Differentiation
by: Ariyanto EF, et al.
Published: (2025-01-01)

First-line chemotherapy for head and neck squamous cell carcinoma. Optimal strategy
by: L. V. Bolotina, et al.
Published: (2019-01-01)

Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors
by: Bao-Tram Thi Tran, et al.
Published: (2023-12-01)

PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues
by: Valerio Costa, et al.
Published: (2010-01-01)

Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis
by: Borja Bandera Merchan, et al.
Published: (2016-01-01)

The effect of postoperative adjuvant chemotherapy on survival outcomes in patients with early stage oral squamous cell carcinoma
by: Yungang He, et al.
Published: (2025-07-01)

Efficacy and safety of nanoparticle albumin-bound paclitaxel plus cisplatin or nedaplatin plus tegafur/gimeracil/oteracil as induction chemotherapy regimen for hypopharyngeal cancer
by: Cailing Jiang, et al.
Published: (2025-02-01)

PROTEIN PHOSPHATASE 1В IN THE PATHOGENESIS OF LARYNGEAL AND HYPOPHARYNGEAL CANCER
by: G. V. Kakurina, et al.
Published: (2017-09-01)

EFNA2 Mediates Stiffness-Regulated Hypopharyngeal Cancer Progression
by: Songqun Hu, et al.
Published: (2025-05-01)

Surgical management of non-traumatic hypopharyngeal perforation with descending mediastinitis
by: Ivoslav Ivanov, et al.
Published: (2025-03-01)

Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
by: Shu-Hang Ng, et al.
Published: (2014-01-01)

Pneumatosis Cystoides Intestinalis after Cetuximab Chemotherapy for Squamous Cell Carcinoma of Parotid Gland
by: Christos Petrides, et al.
Published: (2015-01-01)

Diagnostic value of fasting hypopharyngeal salivary pepsin concentration test for laryngopharyngeal reflux disease
by: Chao‐Feng Liu, et al.
Published: (2025-06-01)

Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
by: Guiqin Hou, et al.
Published: (2014-01-01)

First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis
by: Jing-Wen Han, et al.
Published: (2025-01-01)